To Develop an Arthroscopic Classification of Forms of Degenerative Meniscal Lesions in Patients with Post-Traumatic Gonarthrosis
Downloads
Osteoarthritis occupies a large place in the structure of joint diseases. Gonarthrosis refers to gradually progressive chronic diseases requiring long-term treatment, the immediate results of rehabilitation of which are considered unsatisfactory in 14% of patients, and long-term - in 48%. Further progression of knee joint OA leads to persistent moderate and pronounced impairments of static-dynamic function, and, as a result, to a decrease in the patient's "quality of life", and in some cases even to disability.
1. A controlled trial of arthroscopic surgery for osteoarthritis of the knee / J. B. Moseley et al. // New England journal of medicine. 2002. - Vol. 347. -P. 81-87.
2. Berg Hrachovec J. Reporting of 6-month vs 12- month data in a clinical trial of celecoxib / J. Berg Hrachovec, M. Mora // The journal of American Medical Association. 2001. - Vol. 286. - P. 2398 - 2399.
3. Cederlund I. Osteoarthritis communicators — a unique cooperation beetwen the sports, movement and the Swedish Rheumatism Association / I. Cederlund//Annals of the Rheumatic Diseases.- 2005^ Volt.641-P. 2286:
4. Dodge G. R. Glucosamine sulfate modulates the levels ofaggrecan and matrix metallopteinase-3 synthesized by cultured humanosteoarthritis articular chondrocytes / G. R. Dodge, S. A. Jimenez // Osteoarthritis and cartilage. 2003. -Vol. 11.-P. 424-432.
5. Effect of selective cyclooxygenase 2 inhibitors and naproxen on short-term risk of acute myocardial infarction in the elderly / M. Mamdani et al. // Archives of internal medicine, 2003. Vol. 163. - P. 481 -486.
6. Garcia Rodriguez L. A. The effect of NSAIDs on the risk of coronary heart disease: fusion of clinical pharmacology and pharmacoepidemilogic data / L. A. Garcia Rodriguez // Clinical and experimental rheumatology. 2001. - Vol. 19. -P. 41-45.
7. Hawkey 0. J. Non-steroidal anti-inflammatory drugs: overall risk and management. Comlementary roles for COX 2 inhibitors and' proton pump inhibitors / C. J. Hawkey, M. J. S. Langman // Gut. 2003. - Vol. 52. -P. 600-808.
8. Intermittent treatment of knee osteoarthritis with oral chondroitin sulfate: a one-year, randomized, double-blind, multicenter study versus placebo / D.'Uebelhart et al. // Osteoarthritis and cartilage. 2004. - Vol. 12. - № 4. - P. 269 - 276.
9. Marcus A. J. COX inhibition and thromboregulation / A. J. Marcus, • M.» J. Broekman, G. J. Pinsky // New England journal of medicine. 2002.-Vol. 347.-P. 1025- 1026. ■
10. Silverstein E. The use of intra-articular Hylan G-F 20 in the treatment of symptomatic osteoarthritis of the shoulder a preliminary study / E. Silverstein, R. Leger, K. Shea // The American Journal of Sports Medicine. 2007. -Vol. 35.-P. 979-985.
